{"id":"https://openalex.org/W1903518157","doi":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","title":"Examining the role of oxytocin in the interoceptive effects of 3,4\u2010methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) using a drug discrimination paradigm in the rat","display_name":"Examining the role of oxytocin in the interoceptive effects of 3,4\u2010methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) using a drug discrimination paradigm in the rat","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-11","ids":{"openalex":"https://openalex.org/W1903518157","doi":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","mag":"1903518157","pmid":"https://pubmed.ncbi.nlm.nih.gov/21070509"},"language":"en","primary_location":{"id":"doi:10.1111/j.1369-1600.2010.00267.x","doi":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","pdf_url":null,"source":{"id":"https://openalex.org/S118332200","display_name":"Addiction Biology","issn_l":"1355-6215","issn":["1355-6215","1369-1600"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1903518157"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031680537","display_name":"Jillian Helen Broadbear","orcid":"https://orcid.org/0000-0003-3342-5868","observed_orcids":["https://orcid.org/0000-0003-3342-5868"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Jillian H. Broadbear","raw_affiliation_strings":["School of Psychology and Psychiatry, Monash University, Clayton, Vic. 3800, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Psychology and Psychiatry, Monash University, Clayton, Vic. 3800, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060579186","display_name":"Brendan J. Tunstall","orcid":"https://orcid.org/0000-0001-9430-9612","observed_orcids":["https://orcid.org/0000-0001-9430-9612"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Brendan Tunstall","raw_affiliation_strings":["School of Psychology and Psychiatry, Monash University, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Psychology and Psychiatry, Monash University, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032086556","display_name":"Katherine Beringer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Katherine Beringer","raw_affiliation_strings":["Current address: School of Public Health and Preventive Medicine, Monash University, Clayton 3168, Australia","School of Psychological Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Current address: School of Public Health and Preventive Medicine, Monash University, Clayton 3168, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"School of Psychological Sciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031680537"],"corresponding_institution_ids":["https://openalex.org/I56590836"],"apc_list":{"value":3150,"currency":"USD","value_usd":3150},"apc_paid":null,"fwci":4.8061,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.94258034,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"16","issue":"2","first_page":"202","last_page":"214"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.1696999967098236,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.045899998396635056,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.875},{"id":"https://openalex.org/keywords/ecstasy","display_name":"ecstasy","score":0.984000027179718},{"id":"https://openalex.org/keywords/oxytocin","display_name":"oxytocin","score":0.9589999914169312},{"id":"https://openalex.org/keywords/oxytocin-receptor","display_name":"oxytocin receptor","score":0.9520000219345093},{"id":"https://openalex.org/keywords/carbetocin","display_name":"carbetocin","score":0.8610000014305115},{"id":"https://openalex.org/keywords/atosiban","display_name":"atosiban","score":1.0},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.8830000162124634},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.6629999876022339},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.6349999904632568},{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/interoceptive-cues","display_name":"interoceptive cues","score":0.597000002861023},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.3490000069141388},{"id":"https://openalex.org/keywords/subjective-effects","display_name":"subjective effects","score":0.46399998664855957},{"id":"https://openalex.org/keywords/mood","display_name":"mood","score":0.34200000762939453},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.9336909055709839},{"id":"https://openalex.org/C2776176026","wikidata":"https://www.wikidata.org/wiki/Q169960","display_name":"Oxytocin","level":2,"score":0.7005600333213806},{"id":"https://openalex.org/C181612422","wikidata":"https://www.wikidata.org/wiki/Q14908140","display_name":"Oxytocin receptor","level":3,"score":0.649978756904602},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6365190744400024},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.545124888420105},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.541192889213562},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5394980907440186},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5195346474647522},{"id":"https://openalex.org/C2779488553","wikidata":"https://www.wikidata.org/wiki/Q625143","display_name":"Ecstasy","level":2,"score":0.4932343363761902},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4480913281440735},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4259300231933594},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.41836756467819214},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.37770724296569824},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.31698715686798096},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3109015226364136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27835047245025635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23563754558563232},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.1811215877532959},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.1363408863544464},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.12553393840789795}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003213","descriptor_name":"Conditioning, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003213","descriptor_name":"Conditioning, Psychological","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003463","descriptor_name":"Cues","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004193","descriptor_name":"Discrimination Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004193","descriptor_name":"Discrimination Learning","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006727","descriptor_name":"Hormone Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009042","descriptor_name":"Motivation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009042","descriptor_name":"Motivation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010121","descriptor_name":"Oxytocin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010121","descriptor_name":"Oxytocin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010121","descriptor_name":"Oxytocin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010121","descriptor_name":"Oxytocin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014668","descriptor_name":"Vasotocin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014668","descriptor_name":"Vasotocin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018045","descriptor_name":"Receptors, Oxytocin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018045","descriptor_name":"Receptors, Oxytocin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019969","descriptor_name":"Amphetamine-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1369-1600.2010.00267.x","doi":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1369-1600.2010.00267.x","pdf_url":null,"source":{"id":"https://openalex.org/S118332200","display_name":"Addiction Biology","issn_l":"1355-6215","issn":["1355-6215","1369-1600"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction Biology","raw_type":"journal-article"},{"id":"pmid:21070509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21070509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction biology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1895313399","https://openalex.org/W1965897754","https://openalex.org/W1966163996","https://openalex.org/W1966733439","https://openalex.org/W1973287358","https://openalex.org/W1976495588","https://openalex.org/W1976834001","https://openalex.org/W1977027245","https://openalex.org/W1981056570","https://openalex.org/W1983048332","https://openalex.org/W1985795350","https://openalex.org/W1989161294","https://openalex.org/W1996368170","https://openalex.org/W1998872047","https://openalex.org/W2005206874","https://openalex.org/W2007549333","https://openalex.org/W2009016427","https://openalex.org/W2009559742","https://openalex.org/W2017323063","https://openalex.org/W2018057120","https://openalex.org/W2025534251","https://openalex.org/W2025984201","https://openalex.org/W2031001813","https://openalex.org/W2031414364","https://openalex.org/W2050590928","https://openalex.org/W2050757130","https://openalex.org/W2058110328","https://openalex.org/W2060650244","https://openalex.org/W2061993323","https://openalex.org/W2064576666","https://openalex.org/W2068250894","https://openalex.org/W2070420735","https://openalex.org/W2071107645","https://openalex.org/W2072290412","https://openalex.org/W2080326011","https://openalex.org/W2083481513","https://openalex.org/W2091385849","https://openalex.org/W2093487847","https://openalex.org/W2109384015","https://openalex.org/W2111105497","https://openalex.org/W2118539399","https://openalex.org/W2132011251","https://openalex.org/W2132011757","https://openalex.org/W2137292290","https://openalex.org/W2138559331","https://openalex.org/W2145904740","https://openalex.org/W2171421328","https://openalex.org/W2257621938","https://openalex.org/W2279719644","https://openalex.org/W2319900104"],"related_works":["https://openalex.org/W2099968430","https://openalex.org/W2936074596","https://openalex.org/W2109384015","https://openalex.org/W2071128139","https://openalex.org/W2080312372","https://openalex.org/W1978610961","https://openalex.org/W2066536621","https://openalex.org/W806316479","https://openalex.org/W2272843035","https://openalex.org/W2058110328"],"abstract_inverted_index":{"3,4-Methylenedioxymethamphetamine":[0],"(MDMA,":[1],"'ecstasy')":[2],"use":[3],"results":[4,131,185],"in":[5,36,158,199],"distinctive":[6],"mood":[7,46],"changes":[8],"of":[9,18,23,34,45,58,162,186,212,215],"a":[10,50,84,92,127,159,194],"prosocial":[11],"nature,":[12],"most":[13],"likely":[14],"through":[15],"its":[16],"enhancement":[17],"serotonin":[19],"(5HT)":[20],"neurotransmission.":[21],"Activation":[22],"5HT-1A":[24],"postsynaptic":[25],"receptors":[26,153],"has":[27],"been":[28],"shown":[29],"to":[30,67,78,99,145,171],"stimulate":[31],"the":[32,37,133,146,172,206,213],"release":[33],"oxytocin":[35,59,105,112,139,152,173,190],"central":[38],"nervous":[39],"system":[40],"where":[41],"it":[42,221],"regulates":[43],"aspects":[44],"and":[47,70,83,89,201,204],"behavior.":[48],"Using":[49],"drug":[51,94],"discrimination":[52,95],"paradigm,":[53],"we":[54],"examined":[55],"whether":[56],"modulation":[57],"receptor":[60,113,174,191],"activity":[61],"would":[62,142,156],"affect":[63,181],"conditioned":[64],"behavioral":[65],"responses":[66],"MDMA.":[68],"Male":[69],"female":[71,202],"Sprague":[72],"Dawley":[73],"rats":[74,203],"(n=24)":[75],"were":[76,169],"trained":[77],"reliably":[79],"differentiate":[80],"between":[81],"MDMA":[82,147],"related":[85],"stimulant,":[86],"amphetamine":[87],"(AMP),":[88],"saline":[90],"using":[91],"three-lever":[93],"paradigm.":[96],"The":[97,120,130,184],"extent":[98],"which":[100],"substitution":[101,136],"with":[102,109,137,154],"carbetocin":[103],"(an":[104,111],"analog)":[106],"or":[107],"co-administration":[108],"atosiban":[110,155],"antagonist)":[114],"affected":[115],"drug-appropriate":[116,182],"responding":[117],"was":[118,124],"evaluated.":[119],"tricyclic":[121],"antidepressant":[122],"imipramine":[123,177],"included":[125],"as":[126,176,193],"negative":[128],"control.":[129],"supported":[132],"hypotheses":[134],"that":[135,208,219],"an":[138],"analog":[140],"(carbetocin)":[141],"partially":[143],"generalize":[144],"training":[148],"cue,":[149],"whereas":[150],"blocking":[151],"result":[157],"selective":[160],"disruption":[161],"MDMA--but":[163],"not":[164,180],"AMP-appropriate":[165],"responding.":[166,183],"These":[167],"findings":[168],"specific":[170],"ligands":[175],"pre-treatment":[178],"did":[179],"this":[187,209],"study":[188],"implicate":[189],"activation":[192],"key":[195],"MDMA-specific":[196],"interoceptive":[197],"cue":[198],"male":[200],"support":[205],"conclusion":[207],"is":[210],"one":[211],"features":[214],"MDMA's":[216],"subjective":[217],"effects":[218],"distinguishes":[220],"from":[222],"AMP.":[223]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1903518157","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
